Yu Shi
- Virology top 2%
- Immunology top 5%
- Immune Cell Function and Interaction 8
- T-cell and B-cell Immunology 7
- Biophysics top 5%
- Advanced Fluorescence Microscopy Techniques 6
- Cell Biology top 10%
- Cellular Mechanics and Interactions 7
-
- Angiogenesis and VEGF in Cancer 9
- Ion channel regulation and function 7
- Congenital heart defects research 4
-
- Cardiac electrophysiology and arrhythmias 8
- Co-authors
- Rafick‐Pierre SékalyElias K. HaddadJulien van GrevenyngheJean‐Pierre RoutyMohamed El‐FarFerdinand le NobleElias A. SaidYoav Peretz
- Cited by
- VirologyImmunologyBiophysics
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Nature Medicine (2 papers)Nature Communications (2 papers)
- Partner nations
- United StatesCanadaChina
In The Last Decade
Yu Shi
60 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 126
- Virology 330
- Immunology 756
- Biophysics 70
- Cell Biology 190
- Molecular Biology 668
Countries citing papers authored by Yu Shi
This map shows the geographic impact of Yu Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Shi more than expected).
Fields of papers citing papers by Yu Shi
This network shows the impact of papers produced by Yu Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Shi. The network helps show where Yu Shi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yu Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 15 | |
| 4 | 2024 | 25 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 16 | |
| 7 | 2023 | 5 | |
| 8 | 2022 | 20 | |
| 9 | Long Non-Coding RNA SPRY4-IT1 Reverses Cisplatin Resistance by Downregulating MPZL-1 via Suppressing EMT in NSCLC | 2020 | 1 |
| 10 | 2020 | 2 | |
| 11 | Cisplatin-resistant lung cancer cell–derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100–5p-dependent manner | 2017 | 2 |
| 12 | 2017 | 8 | |
| 13 | 2016 | 39 | |
| 14 | Microvascular invasion in hepatocellular carcinoma overexpression promotes cell proliferation and inhibits cell apoptosis of hepatocellular carcinoma via inhibiting miR-199a expression | 2015 | 1 |
| 15 | Calcifying nanoparticles promote mineralization in vascular smooth muscle cells: implications for atherosclerosis | 2014 | 2 |
| 16 | 2012 | 121 | |
| 17 | 2009 | 31 | |
| 18 | 2008 | 123 | |
| 19 | 2006 | 179 | |
| 20 | Synthesis of Hyperbranched Aromatic Polyamides | 2006 | 1 |
About Yu Shi
Yu Shi is a scholar working on Biophysics, Virology and Structural Biology, having authored 62 papers that have together received 1.9k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (9 papers), Cardiac electrophysiology and arrhythmias (8 papers), Immune Cell Function and Interaction (8 papers), Cellular Mechanics and Interactions (7 papers), Ion channel regulation and function (7 papers), T-cell and B-cell Immunology (7 papers), Advanced Fluorescence Microscopy Techniques (6 papers) and Congenital heart defects research (4 papers). The work is most often cited by research in Virology (330 citations), Immunology (756 citations) and Biophysics (70 citations). Yu Shi has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Rafick‐Pierre Sékaly, Elias K. Haddad, Julien van Grevenynghe, Jean‐Pierre Routy, Mohamed El‐Far, Ferdinand le Noble, Elias A. Said, Yoav Peretz, Bader Yassine‐Diab and Franck P. Dupuy. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.